Cerezyme Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Concise Prescribing Info

Contents

Imiglucerase

Indications/Uses

Long-term enzyme replacement therapy in patients w/ confirmed diagnosis of non-neuronopathic (Type 1) or chronic neuronopathic (Type 3) Gaucher disease who exhibit clinically significant non-neurological manifestations including anemia after exclusion of other causes (eg, Fe deficiency), thrombocytopenia, bone disease after exclusion of other causes (eg, vit D deficiency), hepatomegaly or splenomegaly.

Click to view Cerezyme detailed prescribing information

Dosage/Direction for Use

IV Individualised dosage. Initially 15 u/kg to 60 u/kg once every 2 wk. Administer at 0.5 u/kg/min initial infusion. May be increased at subsequent administrations. Max: 1 u/kg/min.

Click to view Cerezyme detailed prescribing information

Overdosage

View Cerezyme overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Cerezyme detailed prescribing information

Use In Pregnancy & Lactation

Click to view Cerezyme detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Cerezyme detailed prescribing information

Storage

View Cerezyme storage conditions for details to ensure optimal shelf-life.

Description

View Cerezyme description for details of the chemical structure and excipients (inactive components).

Action

View Cerezyme mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Agents Affecting Metabolism

ATC Classification

A16AB02 - imiglucerase ; Belongs to the class of enzymes. Used in the treatment of alimentary tract and metabolism problems.

Regulatory Classification

POM

Presentation/Packing

Form

Cerezyme powd for inj 400 u

Packing/Price

1's

Cerezyme

imiglucerase

Manufacturer:

sanofi-aventis